Omega-3 fatty acids, energy substrates, and brain function during aging.
暂无分享,去创建一个
Anthony Windust | Stephen C Cunnane | Sébastien Tremblay | A. Windust | S. Cunnane | M. Vandal | S. Tremblay | J. Brenna | J. Tremblay-Mercier | Jennifer Tremblay-Mercier | E. Freemantle | Erika Freemantle | Milène Vandal | Jean-Christophe Blachère | Michel E Bégin | J Thomas Brenna | M. Bégin | J. Blachère | M. Bēgin | Milène Vandal
[1] Mark S. Cohen,et al. Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.
[2] D. Williamson,et al. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. , 1980, Physiological reviews.
[3] M. Vranic,et al. Fuel Homeostasis and the Nervous System , 2012, Advances in Experimental Medicine and Biology.
[4] M. Reger,et al. Effects of β-hydroxybutyrate on cognition in memory-impaired adults , 2004, Neurobiology of Aging.
[5] M. Tierney,et al. Fatty acid analysis of blood plasma of patients with alzheimer's disease, other types of dementia, and cognitive impairment , 2000, Lipids.
[6] J. Lindsay,et al. Omega-3 fatty acids and risk of cognitive impairment and dementia. , 2003, Journal of Alzheimer's disease : JAD.
[7] L. Sokoloff,et al. Measurement of local cerebral glucose utilization and its relation to local functional activity in the brain. , 1991, Advances in experimental medicine and biology.
[8] T. Dolecek,et al. Epidemiological Evidence of Relationships between Dietary Polyunsaturated Fatty Acids and Mortality in the Multiple Risk Factor Intervention Trial , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[9] D. Loewenstein,et al. Viability of Neocortical Function Shown in Behavioral Activation State PET Studies in Alzheimer Disease , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] H. Tuokko,et al. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. , 1993, Journal of gerontology.
[11] L. Thompson,et al. Dietary sources and metabolism of α-linolenic acid. , 2003 .
[12] J. Edmond. Ketone bodies as precursors of sterols and fatty acids in the developing rat. , 1974, The Journal of biological chemistry.
[13] D. Bennett,et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. , 2003, Archives of neurology.
[14] B. Heude,et al. Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. , 2003, The American journal of clinical nutrition.
[15] F. Pifferi,et al. (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. , 2005, The Journal of nutrition.
[16] Kazunori Sato,et al. Effect of β-Hydroxybutyrate, a Cerebral Function Improving Agent, on Cerebral Hypoxia, Anoxia and Ischemia in Mice and Rats , 2001 .
[17] Douglas L. Rothman,et al. Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.
[18] B. Lawlor,et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study , 2003, British Journal of Nutrition.
[19] W. Burnham,et al. Dietary Fat, Ketosis, and Seizure Resistance in Rats on the Ketogenic Diet , 2000, Epilepsia.
[20] P. Ferré,et al. Ketone body transport in the human neonate and infant. , 1986, The Journal of clinical investigation.
[21] L. Thompson,et al. Flaxseed in Human Nutrition , 1995 .
[22] N. Balak,et al. Costs of disorders of the brain in Europe , 2007, European journal of neurology.
[23] G F Cahill,et al. Brain metabolism during fasting. , 1967, The Journal of clinical investigation.
[24] K. Kristensson,et al. Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease , 1991, Lipids.
[25] Jean-François Dartigues,et al. Fish, meat, and risk of dementia: cohort study , 2002, BMJ : British Medical Journal.
[26] A. Hofman,et al. Dietary fat intake and the risk of incident dementia in the Rotterdam study , 1997, Annals of neurology.
[27] R N Kalaria,et al. Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease , 1989, Journal of neurochemistry.
[28] S. Amiel,et al. Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute cerebral utilization of a non-glucose fuel. , 1991, Clinical science.
[29] S. Vermunt,et al. Effects of age and dietary n-3 fatty acids on the metabolism of [13C]-α-linolenic acid , 2007, Lipids.
[30] Denis A. Evans,et al. Fish consumption and cognitive decline with age in a large community study. , 2005, Archives of neurology.
[31] A. A. Spector,et al. Eicosapentaenoic acid metabolism in brain microvessel endothelium: effect on prostaglandin formation. , 1989, Journal of lipid research.
[32] D. Horrobin,et al. Ethyl-EPA in Alzheimer's disease--a pilot study. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.
[33] R. Bazinet,et al. Why is carbon from some polyunsaturates extensively recycled into lipid synthesis? , 2003, Lipids.
[34] P. Cryer,et al. Effect of Hyperketonemia and Hyperlacticacidemia on Symptoms, Cognitive Dysfunction, and Counterregulatory Hormone Responses During Hypoglycemia in Normal Humans , 1994, Diabetes.
[35] Brennan Jt. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. , 2002 .
[36] J. Hibbeln,et al. Physiological compartmental analysis of !-linolenic acid metabolism in adult humans , 2013 .
[37] J. Downing,et al. Dietary n-3 and n-6 fatty acids alter avian glucose metabolism , 2005, British poultry science.
[38] G. Mitchell,et al. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.
[39] W. Grant. Dietary Links to Alzheimer's Disease , 1997 .
[40] A. Morris,et al. Cerebral ketone body metabolism , 2005, Journal of Inherited Metabolic Disease.
[41] J. Freeman,et al. The Ketogenic Diet: A Treatment for Epilepsy , 2000 .
[42] P. Shekelle,et al. Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases. , 2005, Evidence report/technology assessment.
[43] Stephen C Cunnane,et al. Breath acetone predicts plasma ketone bodies in children with epilepsy on a ketogenic diet. , 2006, Nutrition.
[44] A. Muir,et al. Flax: The genus Linum , 2003 .
[45] S. Craft,et al. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. , 2004, European journal of pharmacology.
[46] G. Alexander,et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[47] M. Lavialle,et al. Glucose transport and utilization are altered in the brain of rats deficient in n‐3 polyunsaturated fatty acids , 2002, Journal of neurochemistry.
[48] A R Damasio,et al. Quantitative computed tomographic analysis in the diagnosis of dementia. , 1983, Archives of neurology.
[49] D. Chisholm,et al. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. , 1993, The New England journal of medicine.
[50] L. Cleland,et al. Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. , 2003, The American journal of clinical nutrition.
[51] M. Patel,et al. DEVELOPMENT AND REGULATION OF LIPID SYNTHESIS FROM KETONE BODIES BY RAT BRAIN , 1977, Journal of neurochemistry.
[52] Y. Katayama,et al. Effect of long-term administration of ethyl eicosapentate (EPA-E) on local cerebral blood flow and glucose utilization in stroke-prone spontaneously hypertensive rats (SHRSP) , 1997, Brain Research.
[53] M. Kekomäki,et al. OXIDATION OF GLUCOSE and D‐B‐OH‐BUTYRATE BY THE EARLY HUMAN FETAL BRAIN , 1975, Acta paediatrica Scandinavica.
[54] P. Kris-Etherton,et al. Dietary α-Linolenic Acid Reduces Inflammatory and Lipid Cardiovascular Risk Factors in Hypercholesterolemic Men and Women , 2004 .
[55] P. Pencharz,et al. A comparison of the metabolism of eighteen-carbon 13C-unsaturated fatty acids in healthy women Published, JLR Papers in Press, December 16, 2003. DOI 10.1194/jlr.M300304-JLR200 , 2004, Journal of Lipid Research.
[56] M. Laville,et al. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. , 2002, Obesity research.
[57] K. Heininger,. The cerebral glucose-fatty acid cycle: evolutionary roots, regulation, and (patho)physiological importance. , 2002, International review of neurobiology.
[58] T. Montine,et al. Fatty acid oxidation in the pathogenesis of Alzheimer's disease. , 2005, The American journal of pathology.
[59] I. Skoog. Detection of preclinical Alzheimer's disease. , 2000, The New England journal of medicine.
[60] N. Foster,et al. Alzheimer's disease , 1983, Neurology.
[61] J. Olesen,et al. Cost of disorders of the brain in Europe , 2005, European journal of neurology.
[62] S. Stone-Elander,et al. Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. , 2002, American journal of physiology. Endocrinology and metabolism.
[63] G. Alexander,et al. Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism , 2005 .
[64] S. Stone-Elander,et al. Use of R-beta-[1-11C]hydroxybutyrate in PET studies of regional cerebral uptake of ketone bodies in humans. , 1995, The American journal of physiology.
[65] L. Madsen,et al. In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation. , 1999, The Biochemical journal.